Goldman Sachs’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
Other funds holding SBRA
CIM
Goldman Sachs's SBRA Position: Q2 2026 in Review
Goldman Sachs reduced its Sabra Healthcare REIT (SBRA) stake by 7.9% in Q2 2026, selling an estimated $5.84M and leaving 3,439,531 shares worth $67.1M. The position accounts for 0.01% of the portfolio, ranked #1554.
Goldman Sachs first reported a position in SBRA in Q2 2013 and has held it in 53 quarters since. The position peaked at $81.7M in Q1 2022. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.
- Goldman Sachs held 3,439,531 shares of Sabra Healthcare REIT worth $67.1M as of Q2 2026.
- Goldman Sachs sold 294,410 Sabra Healthcare REIT shares in Q2 2026, an estimated $5.84M.
- Sabra Healthcare REIT made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1554 holding.
- Goldman Sachs first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 53 quarters since.
- Goldman Sachs's Sabra Healthcare REIT position peaked at $81.7M in Q1 2022.
- 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.